Buy Daliresp 250 ug/1 roflumilast

Daliresp 250 µg tablets contain roflumilast, a medication used to manage chronic obstructive pulmonary disease (COPD). This oral treatment helps reduce inflammation in the lungs, aiding breathing. Learn more about roflumilast uses and benefits.

Strength

250 ug/1

Pack Size

10 BLISTER PACK in 1 BOX, UNIT-DOSE (0310-0088-39) / 2 TABLET in 1 BLISTER PACK

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Daliresp 250 µg tablets are primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Roflumilast, the active ingredient, works by reducing inflammation in the lungs, which can help improve breathing and reduce symptoms like wheezing and shortness of breath. This medication is not a rescue inhaler and should not be used for sudden breathing problems. Always consult a healthcare provider to determine if roflumilast is suitable for your condition.

Side Effects

Common effects of Daliresp 250 µg tablets may include headache, diarrhea, nausea, and weight loss. Some users might experience insomnia or dizziness. These effects vary among individuals and are not exhaustive. If you experience severe or persistent side effects, consult a healthcare professional.

Precautions & Warnings

Daliresp 250 µg tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Keep the tablets out of reach of children and pets. Do not share this medication with others, even if they have similar symptoms. Always follow the advice of a healthcare provider regarding the use of roflumilast.

Avoid Interactions

Daliresp 250 µg tablets may interact with other medications, including those metabolized by the liver's CYP enzymes. Alcohol consumption should be avoided as it may exacerbate side effects. Inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.

References

Frequently Asked Questions

Daliresp 250 µg tablets are used for the maintenance treatment of chronic obstructive pulmonary disease (COPD).

Store Daliresp 250 µg tablets in a cool, dry place away from direct sunlight and keep them out of reach of children and pets.

Common side effects may include headache, diarrhea, nausea, weight loss, insomnia, and dizziness.

It is advisable to avoid alcohol while taking Daliresp 250 µg tablets as it may worsen side effects.

No, Daliresp 250 µg tablets are not a rescue inhaler and should not be used for sudden breathing problems.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.